Aug 31, 2022 05:38 PM (GMT+8) · EqualOcean
MGI (Chinese: 华大智造), a leading company in China’s gene sequencing industry. The company is expected to issue nearly 41.32 million shares at CNY 87.18 per share. A-share capital market will soon welcome the first stock of core tools in the field of life science and technology. According to public resources, MGI specializes in life science and technology, focusing on the R&D, production and sales of gene sequencing instruments, reagents and related products. Currently, MGI has become one of the few high-end manufacturers in the world capable of independently developing and producing clinical-grade sequencers.